10-Mar-2014 - Bristol-Myers Squibb says 160 jobs will be affected in Ireland as changing market demand drives the closure of an API plant.
10-Mar-2014 - Publication of a US FDA enforcement report detailing a recall conducted by Ranbaxy in January saw the beleaguered Indian drugmakers’ share price fall 3% last week.
05-Mar-2014 - Addiction doctors have petitioned the US FDA to prevent Zohydro ER, the first single-entity hydrocodone painkiller, hitting the market this month citing its potential for abuse. Its maker, Zogenix, has been tight-lipped on whether the drug’s formulation uses anti-abuse technology.
27-Feb-2014 - BASF has hiked its prices for ethanolamines in Europe citing continuous demand increase.
26-Feb-2014 - Pharma industry employees and wholesalers with access to narcotic APIs would be subject to background checks and drug testing under new proposals being considered in the US.
25-Feb-2014 - Ranbaxy has temporarily halted all shipments from two API plants currently under a US FDA consent decree, although both the firm and an analyst say a shortage is unlikely.
19-Feb-2014 - The European Commission (EC) has increased the pressure on Ireland, Italy, Poland and Slovenia to fall into line with other EU member States and introduce anti-drug counterfeiting legislation.
17-Feb-2014 - AMRI says it intends to expand its API business to target both generics and more complex molecules after reporting record full year revenue from contract services.
17-Feb-2014 - Sinopharm expects customer drug launches and its recent investment in cancer injectables to drive revenue gains and margin growth in 2014.
13-Feb-2014 - A Hong Kong API distributor has received a Warning Letter from the US FDA after failing to have a Quality Unit and incorrectly labelling products.
12-Feb-2014 - It is too early to predict what impact proposed changes to US rules on chemical plant security and anti-terrorism measures would have on the drug industry according to PhRMA.
04-Feb-2014 - CRO Ergomed Clinical Research has partnered with Ferrer to support a Phase IIa study of the insomnia drug Lorediplon.
04-Feb-2014 - Johnson Matthey's decision to restructure its narcotic API business in light of increased UK competition has paid off, the company says.
04-Feb-2014 - The UK’s drug regulator is overhauling the way it manages its pharmaceutical manufacturer inspections to deal with its growing burden of site visits.
03-Feb-2014 - Shipments of chicken pox vaccines from a troubled Belgian facility should recommence in early Q2 2014, says GSK, though the root cause of the manufacturing issues are still unknown.
30-Jan-2014 - Clarus Therapeutics has submitted to the FDA a testosterone replacement it claims overcomes the toxicity problems that have plagued other oral drugs like methyltestosterone.
30-Jan-2014 - CordenPharma has received certification of Potent Compound Safety at a US plant and joins a growing list of drugmakers looking to assure HPAPI safety, according to SafeBridge Consultants.
30-Jan-2014 - Increasing demand for HPAPIs has driven Patheon to invest in its Milton Park, UK manufacturing facility, the company says.
30-Jan-2014 - Big pharma rivals are joining forces to pursue a new generation of sophisticated counterfeiters, according to Pfizer and Eli Lilly.
29-Jan-2014 - Northwest Biotherapeutics has agreed with CMO Cognate Bioservices to begin a large-scale expansion of the manufacturing, storage, handling and distribution of its personalized immune therapies for solid tumor cancers.
Most new drug candidates suffer from poor water- solubility leading to rate limiting dissolution, slow absorption and limited bioavail...
Excipients designed to enhance skin penetration can maximize the efficacy of topical formulations. Through lipid disruption and...
Do you want a big-selling probiotic product portfolio?A recent published study proves a 68% effect in 4 weeks on allevia...